Advertisement

 

 

Incidental Detection of Medullary Thyroid Carcinoma by 68Ga-DOTATATE PET/CT in a Patient With Neuroendocrine Tumor Liver Metastases.

Incidental Detection of Medullary Thyroid Carcinoma by 68Ga-DOTATATE PET/CT in a Patient With Neuroendocrine Tumor Liver Metastases.
Author Information (click to view)

Mahajan S, Shaha A, Grewal RK,


Mahajan S, Shaha A, Grewal RK, (click to view)

Mahajan S, Shaha A, Grewal RK,

Advertisement

Clinical nuclear medicine 43(2) 136-138 doi 10.1097/RLU.0000000000001950

Abstract

Ga-DOTATATE, a positron-emitting somatostatin analog, has been approved by the Food and Drug Administration for imaging neuroendocrine tumors (NETs). The presence of a second primary malignancy is common in NETs; however, synchronous primary malignancy in the thyroid has rarely been reported. The value of Ga-DOTATATE in medullary thyroid cancer is being investigated and is currently recommended for use when treatment with somatostatin analogs is an option. We present a 55-year-old man with abdominal pain associated with well-differentiated NET liver metastases and incidental medullary thyroid carcinoma demonstrated on a Ga-DOTATATE PET/CT.

Submit a Comment

Your email address will not be published. Required fields are marked *

16 + 16 =

[ HIDE/SHOW ]